Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (ECH1) is an enzyme encoded by the human ECH1 gene that catalyzes the isomerization of 3-trans,5-cis-dienoyl-CoA to 2-trans,4-trans-dienoyl-CoA as part of the auxiliary pathway of fatty acid β-oxidation[1][3][9]. It belongs to the hydratase/isomerase superfamily, localizes primarily to peroxisomes and mitochondria, and helps metabolize unsaturated fatty acids with conjugated double bonds[3]. Altered expression or function of ECH1 has been implicated in metabolic conditions such as adrenoleukodystrophy, steatohepatitis, and myocardial infarction[1][4][7]. The gene product may serve as a biomarker for hepatic disease but is not currently a direct drug target.
Not specifically applicable, as ECH1 is not currently a direct drug target. Drugs affecting fatty acid oxidation or peroxisome proliferators may affect ECH1 activity indirectly[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (ECH1).